Alpine immune: rebuilding itself from scratch, but long way to go before proof

Last year, ALPN ditched its lead program after a second patient death in a CD28 molecule, a previously notorious ...

March 29, 2023, 7:37 am

Alibaba split: ‘if you control the data, you control the business,' tematica research cio say

Tematica Research Chief Investment Officer Christopher Versace joins Yahoo Finance Live to discuss the tech sector, investor sentiment, the Fed's poli...

March 28, 2023, 10:00 am

Aurinia pharmaceuticals: all in on lupkynis - a tough bet

LUPKYNIS has had a lengthy and ultimately productive development pathway. Aurinia has gone all hands on...

March 24, 2023, 12:53 am

Compass pathways earns repeat ‘buy' rating and us$60 price target on adjusted trial design for comp360

Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have reiterated their ‘Buy' rating and US$60 price target for COMPASS ...

March 13, 2023, 2:46 pm

The university of findlay offers a distance pathway to a doctor of pharmacy degree

Findlay, March 08, 2023 (GLOBE NEWSWIRE) — Findlay, Ohio – The University of Findlay (UF) has expanded its graduate degree programming by offering...

March 8, 2023, 6:08 pm

2 growth stocks with incredible potential in the next 5 years

Biotech stocks are risky, but high-potential plays can pay off big. Compass pathways is making progress...

March 6, 2023, 8:30 am

Immuneering presents preclinical data with lead program imm-1-104 supporting universal-ras activity

Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS...

March 5, 2023, 11:30 pm

Compass pathways to participate in upcoming cowen 43rd annual health care conference, oppenheimer 33rd annual healthcare conference, and loop capital investor conference

LONDON, March 02, 2023 (GLOBE NEWSWIRE) -- COMPASS pathways plc (Nasdaq: CMPS), a mental health care co...

March 2, 2023, 10:23 am

Compass pathways plc to announce fourth quarter and year-end 2022 financial results on 28 february 2023

Conference call to be held at 8:00am ET (1:00pm UK) Conference call to be held at 8:00am ET (1:00pm UK)...

February 24, 2023, 12:01 pm

Perk labs highlights addition of diverse, high-margin revenue streams in fiscal 2022

Perk Labs Inc said during fiscal 2022 it diversified its revenue sources to establish a long-term pathway...

February 21, 2023, 11:44 am

Could this boring stock be a 10-bagger by 2030?

This "legacy" company has several overlooked potential growth pathways....

February 20, 2023, 6:18 am

Artelo biosciences to present at microcap rodeo's annual winter wonderland – best ideas virtual investor conference on february 22, 2023

SOLANA BEACH, CA / ACCESSWIRE / February 15, 2023 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulat...

February 15, 2023, 8:30 am

Verve therapeutics announces verve-101 awarded innovation passport by the uk mhra for the treatment of heterozygous familial hypercholesterolemia

BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of c...

February 14, 2023, 11:30 am

We live in interesting times: fannie and freddie, the scotus remand, and the 5th circuit

SCOTUS has already decided on some GSE-related issues but has remanded other issues to the 5th Circuit. Given similar fact situations, they may decid...

February 14, 2023, 5:05 am

Travere: sparsentan approval is likely, but future is uncertain

IgA Nephropathy (IgAN) is a chronic autoimmune disease that affects the kidneys and leads to end-stage kidney disease. Current treatments for IgAN are...

February 13, 2023, 5:23 pm

Ultragenyx: rating speculative buy, playing setrusumab data release

Ultragenyx has been punished on the chart over the past 2 years to date. Investors haven't rewarded the company's top-line growth, nor recognized the ...

February 10, 2023, 4:07 am

Erasca: potential strong upside ahead

Erasca, Inc. is a clinical-stage biopharmaceutical developer of therapies for patients with RAS/MAPK pathway...

February 8, 2023, 11:21 am

Australia's trade minister says working with china to resume full trade

The Australian Trade Minister Farrell says will travel to Beijing, at China's invitation:

• will meet Chinese counterpart soon
• the...

  February 6, 2023, 4:27 am

Erasca to present at the guggenheim oncology conference 2023

SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoverin...

February 1, 2023, 8:00 am

Zentalis pharmaceuticals to participate in two upcoming investor conferences

NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company fo...

February 1, 2023, 7:01 am